HOME › DRUGS › ESCITALOPRAM OXALATE
ACTIVE SUBSTANCE / INN

ESCITALOPRAM OXALATE

Brand name(s): LEXAPRO, ESCITALOPRAM, ESCITALOPRAM OXALATE
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
ANDA078219
NDA219130
ACTIVE SUBSTANCE
Escitalopram Oxalate
REGULATORS
FDA
SPONSORS / MAH
ABBVIE, CARACO, INVAGEN PHARMS
TOTAL APPLICATIONS
7
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ESCITALOPRAM OXALATEANDA077660RISINGDiscontinued
ESCITALOPRAM OXALATEANDA078604INVAGEN PHARMSPrescription
ESCITALOPRAMNDA219130ALMATICAPrescription
ESCITALOPRAM OXALATEANDA078219CARACONone (Tentative Approval)
ESCITALOPRAMANDA076981ALPHAPHARMNone (Tentative Approval)
LEXAPRONDA021323ABBVIEPrescription
LEXAPRONDA021365ABBVIEDiscontinued

FULL INTELLIGENCE ON ESCITALOPRAM OXALATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →